Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosis

By Hartmann R.W.   Muller U.   Ehmer P.B.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 363-366

Elsevier

Access to resources Recommend Favorite

Lack of association between ABCC2 gene variants and treatment response in epilepsy

By Hilger Eva   Reinthaler Eva Maria   Stogmann Elisabeth   Hotzy Christoph   Pataraia Ekaterina   Baumgartner Christoph   Zimprich Alexander   Zimprich Fritz  

Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. : 185-190

Future Medicine

Access to resources Recommend Favorite

New CYP2A6 gene deletion and conversion variants in a population of Black African descent

By Mwenifumbo Jill C   Zhou Qian   Benowitz Neal L   Sellers Edward M   Tyndale Rachel F  

Pharmacogenomics, Vol. 11, Iss. 2, 2010-02 ,pp. : 189-198

Future Medicine

Access to resources Recommend Favorite

Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants

By Montané Jaime Lazara Karelia   Lalla Anthony   Steimer Werner   Gaedigk Andrea  

Pharmacogenomics, Vol. 14, Iss. 3, 2013-02 ,pp. : 261-276

Future Medicine

Access to resources Recommend Favorite

Research Highlights: CYP2C19 genetic variants and clopidogrel responsiveness in acute coronary syndrome: are we ready for individualized therapy?

By Giusti Betti   Gori Anna Maria   Marcucci Rossella   Abbate Rosanna  

Pharmacogenomics, Vol. 10, Iss. 7, 2009-07 ,pp. : 1131-1133

Future Medicine

Access to resources Recommend Favorite